The Cardiff Blues will be giving there support to Velindre Hospital 'Stepping Stones Appeal' with a collection at the Cardiff Blues v Toulouse match.
There are nearly 2000 people newly diagnosed with lung cancer in Wales every year, so it is a significant health problem. Although most cases are associated with smoking, we are seeing and increasing number of sufferers who have never smoked. More people in the UK survive cancer now than ever thanks to early detection and better treatments.
Velindre Cancer Centre Lung Cancer Research Department have launched the 'Stepping Stones Appeal' to increase awareness of our work, and to raise the money necessary to continue to fund and expand our research programmes. The Lung Cancer Research Fund at Velindre Cancer Centre is managed by Dr Jason Lester and funds local research into treatments and management of the illness. Although lung cancer is the most common form of cancer death in Wales, lung cancer research has been relatively poorly supported compared to other higher profile forms of cancer. Despite record spending on research, other cancers with higher profiles and better survival rates receive nearly receive nearly two thirds of the money.
The Stepping Stones Appeal will provide:
Funding for local lung cancer research projects. It is increasingly difficult to fund research in medicine. Increased income means we will be able to provide support for local research projects looking at improving patient care.
Educational grants to doctors, nurses and other health professionals involved in the care of lung cancer patients. This will help us to provide the best care possible for lung cancer patients.
Equipment provision. Advances in technology mean that treatment is being delivered more efficiently and safely. The Stepping Stones Appeal will help purchase equipment to improve the way we treat lung cancer patients.
Despite encouraging progress over the last few years, lung cancer remains a difficult disease to treat. Your support of the Stepping Stones Appeal will help us to advance our research into lung cancer, stage by stage, step by step.